Having trouble accessing articles? Reset your cache.

CXA-101: Phase II data

Data from the mMITT population (n=103) of a double-blind, active-controlled, international Phase II trial showed that IV CXA-101 every 8 hours for 7-10 days led to a microbiologic cure rate of 83% at

Read the full 333 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE